Cargando…

Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy

Retinal oxidative damage, associated with an ATP-binding cassette, sub-family A, member 4, also known as ABCA4 gene mutation, has been implicated as a major underlying mechanism for Stargardt disease/fundus flavimaculatus (STG/FF). Recent findings indicate that saffron carotenoid constituents crocin...

Descripción completa

Detalles Bibliográficos
Autores principales: Piccardi, Marco, Fadda, Antonello, Martelli, Francesco, Marangoni, Dario, Magli, Adriano, Minnella, Angelo M., Bertelli, Matteo, Di Marco, Stefano, Bisti, Silvia, Falsini, Benedetto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835540/
https://www.ncbi.nlm.nih.gov/pubmed/31618812
http://dx.doi.org/10.3390/nu11102461
_version_ 1783466696394145792
author Piccardi, Marco
Fadda, Antonello
Martelli, Francesco
Marangoni, Dario
Magli, Adriano
Minnella, Angelo M.
Bertelli, Matteo
Di Marco, Stefano
Bisti, Silvia
Falsini, Benedetto
author_facet Piccardi, Marco
Fadda, Antonello
Martelli, Francesco
Marangoni, Dario
Magli, Adriano
Minnella, Angelo M.
Bertelli, Matteo
Di Marco, Stefano
Bisti, Silvia
Falsini, Benedetto
author_sort Piccardi, Marco
collection PubMed
description Retinal oxidative damage, associated with an ATP-binding cassette, sub-family A, member 4, also known as ABCA4 gene mutation, has been implicated as a major underlying mechanism for Stargardt disease/fundus flavimaculatus (STG/FF). Recent findings indicate that saffron carotenoid constituents crocins and crocetin may counteract retinal oxidative damage, inflammation and protect retinal cells from apoptosis. This pilot study aimed to evaluate central retinal function following saffron supplementation in STG/FF patients carrying ABCA4 mutations. Methods: in a randomized, double-blind, placebo-controlled study (clinicaltrials.gov: NCT01278277), 31 patients with ABCA4-related STG/FF and a visual acuity >0.25 were randomly assigned to assume oral saffron (20 mg) or placebo over a six month period and then reverted to P or S for a further six month period. Full ophthalmic examinations, as well as central 18° focal electroretinogram (fERG) recordings, were performed at baseline and after six months of either saffron or placebo. The fERG fundamental harmonic component was isolated by Fourier analysis. Main outcome measures were fERG amplitude (in µV) and phase (in degrees). The secondary outcome measure was visual acuity. Results: supplement was well tolerated by all patients throughout follow-up. After saffron, fERG amplitude was unchanged; after placebo, amplitude tended to decrease from baseline (mean change: −0.18 log µV, p < 0.05). Reverting the treatments, amplitude did not change significantly. fERG phase and visual acuity were unchanged throughout follow-up. Conclusions: short-term saffron supplementation was well tolerated and had no detrimental effects on the electroretinographic responses of the central retina and visual acuity. The current findings warrant further long-term clinical trials to assess the efficacy of saffron supplementation in slowing down the progression of central retinal dysfunction in ABCA4-related STG/FF.
format Online
Article
Text
id pubmed-6835540
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-68355402019-11-25 Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy Piccardi, Marco Fadda, Antonello Martelli, Francesco Marangoni, Dario Magli, Adriano Minnella, Angelo M. Bertelli, Matteo Di Marco, Stefano Bisti, Silvia Falsini, Benedetto Nutrients Brief Report Retinal oxidative damage, associated with an ATP-binding cassette, sub-family A, member 4, also known as ABCA4 gene mutation, has been implicated as a major underlying mechanism for Stargardt disease/fundus flavimaculatus (STG/FF). Recent findings indicate that saffron carotenoid constituents crocins and crocetin may counteract retinal oxidative damage, inflammation and protect retinal cells from apoptosis. This pilot study aimed to evaluate central retinal function following saffron supplementation in STG/FF patients carrying ABCA4 mutations. Methods: in a randomized, double-blind, placebo-controlled study (clinicaltrials.gov: NCT01278277), 31 patients with ABCA4-related STG/FF and a visual acuity >0.25 were randomly assigned to assume oral saffron (20 mg) or placebo over a six month period and then reverted to P or S for a further six month period. Full ophthalmic examinations, as well as central 18° focal electroretinogram (fERG) recordings, were performed at baseline and after six months of either saffron or placebo. The fERG fundamental harmonic component was isolated by Fourier analysis. Main outcome measures were fERG amplitude (in µV) and phase (in degrees). The secondary outcome measure was visual acuity. Results: supplement was well tolerated by all patients throughout follow-up. After saffron, fERG amplitude was unchanged; after placebo, amplitude tended to decrease from baseline (mean change: −0.18 log µV, p < 0.05). Reverting the treatments, amplitude did not change significantly. fERG phase and visual acuity were unchanged throughout follow-up. Conclusions: short-term saffron supplementation was well tolerated and had no detrimental effects on the electroretinographic responses of the central retina and visual acuity. The current findings warrant further long-term clinical trials to assess the efficacy of saffron supplementation in slowing down the progression of central retinal dysfunction in ABCA4-related STG/FF. MDPI 2019-10-15 /pmc/articles/PMC6835540/ /pubmed/31618812 http://dx.doi.org/10.3390/nu11102461 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Piccardi, Marco
Fadda, Antonello
Martelli, Francesco
Marangoni, Dario
Magli, Adriano
Minnella, Angelo M.
Bertelli, Matteo
Di Marco, Stefano
Bisti, Silvia
Falsini, Benedetto
Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
title Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
title_full Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
title_fullStr Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
title_full_unstemmed Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
title_short Antioxidant Saffron and Central Retinal Function in ABCA4-Related Stargardt Macular Dystrophy
title_sort antioxidant saffron and central retinal function in abca4-related stargardt macular dystrophy
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6835540/
https://www.ncbi.nlm.nih.gov/pubmed/31618812
http://dx.doi.org/10.3390/nu11102461
work_keys_str_mv AT piccardimarco antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT faddaantonello antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT martellifrancesco antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT marangonidario antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT magliadriano antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT minnellaangelom antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT bertellimatteo antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT dimarcostefano antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT bistisilvia antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy
AT falsinibenedetto antioxidantsaffronandcentralretinalfunctioninabca4relatedstargardtmaculardystrophy